<DOC>
	<DOCNO>NCT00548340</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety 5 week double-blind treatment period VEC-162 compare placebo male female patient primary insomnia .</brief_summary>
	<brief_title>VEC-162 Study Adult Patients With Primary Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>Males female diagnosis primary insomnia define DSMIV . Habitual bedtime 9:00 pm 1:00 . No history evidence restless leg syndrome periodic limb movement disorder sleep apnea . Patients must sign write consent form . History drug alcohol abuse define DSMIV . History psychiatric disorder , include Major Depressive Disorder , Generalized Anxiety Disorder delirium . History chronic obstructive pulmonary disease ( COPD ) , seizures , sleep apnea , narcolepsy , circadianrhythm sleep disorder , parasomnia sleep disorder chronic insomnia . Recent history shift work jet lag .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>